Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund (CBRF-BRIF)
Stage 2—Selection criteria descriptions


On this page


The following descriptions are intended to assist applicant institutions and committee members by further elaborating the selection criteria specific to the Stage 2 Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund (CBRF-BRIF) scientific and technical review, as well as the strategic review. These descriptions are not exhaustive. There may be additional elements that address the selection criteria listed in the CBRF-BRIF funding opportunity description and applicant instructions. The onus is on the applicant institutions to provide enough appropriate information to enable committee members to assess their application according to the selection criteria.

Each proposal can include one or more of the following components:

Each research infrastructure or talent development component must directly support one or more proposals comprising a research component. The Scientific and Technical Review Committee first evaluates the scientific and technical merit of the proposal components according to each component type’s (research, talent development or research infrastructure) respective criteria.

Following this review, the Strategic Review Committee will assess proposals’ alignment with the strategic objectives of the program and with the priorities of Canada’s Biomanufacturing and Life Sciences Strategy (the Strategy). Informed by strategic considerations, the results of the scientific and technical review and provincial priorities (for infrastructure components only), the Strategic Review Committee will ultimately recommend a portfolio of proposals that best support the Strategy and benefit Canada.

For the CBRF-BRIF funding opportunity, highly qualified personnel (HQP) refers to students, research technicians, postdoctoral researchers, research associates and other technical or research personnel with the potential to contribute to Canada’s bioeconomy.

An early career researcher (ECR) is a researcher within five years of the start date of their first research-related appointment, minus the length of any eligible delays in research (e.g., illness, maternity, parental), as of the first day of the month in which the competition is launched.

In-kind contributions for research and talent development components include eligible nonmonetary resources that partners or administering institutions provide to support the project. These contributions could be in the form of cash-equivalent goods or services that , if not donated, would have to be purchased with project funds. In-kind contributions could also include the time of individuals within partner organizations (e.g., experts in a specific area) spent providing direction and participating in the project. In some cases, partners may provide specialized skills and advice or access to special equipment, space, data sets, etc.

Scientific and technical selection criteria

Research criteria

Relevance
Extent to which the research component’s objectives and design meet the hub’s vision, priorities and program of research
Partnered, applied research that supports the hub’s vision, priorities and program of research The research objectives and design are aligned with the endorsing hub’s vision, priorities and program of research.
Effectiveness
Extent to which the research component is expected to achieve its objectives
Scientific excellence of the research activities The excellence of the research activities is demonstrated by positioning them within the current state of knowledge in the field, both in Canada and internationally.
Appropriateness and feasibility of the research activities

The research activities are feasible and are likely to result in the expected outcomes. There is a description of methodological limitations and plans to mitigate limitations, as appropriate.

The methodological approach(es) and design of the research component are well suited to the objectives. The approach(es) include sex- and gender-based analysis (SGBA) and/or gender-based analysis plus (GBA+) and demonstrate active engagement and collaboration with First Nations, Inuit and Métis communities, as appropriate.

Infrastructure and tools are appropriate for carrying out the research activities. Materials, processes and procedures used and developed are in accordance with established standards such as Good Laboratory Practices and Good Manufacturing Practices, as applicable.

Necessary expertise to deliver on the component’s objectives. The research team has the breadth and depth of expertise, perspectives and capacity, from all relevant sectors and disciplines, to conduct the research activities and meet the objectives of the research component.
Efficiency
Extent to which the research component is likely to deliver results in an efficient and timely manner
Appropriateness of the scope and timeline The scope of the research activities is appropriate to the duration of the funding as well as the described methodological approaches, design and objectives. The timeline considers infrastructure availability, including the time necessary for infrastructure acquisitions, construction or licencing, as appropriate.
Appropriateness of the budget The budget is appropriate to undertake and complete the research activities outlined.
Effectiveness of the oversight structure(s) and plan(s)

The oversight structure(s) and plan(s) reflect the objectives, breadth and complexity of the research component. There is evidence that the governance and/or administrative plan(s) will guide the research activities. Plans should include:

  • appropriate methods and indicators for monitoring progress and assessing outcomes;
  • a description of the specific roles and expertise of members involved in the governance structure; and
  • data management considerations, as appropriate.
Impact
Extent to which the research component is expected to generate significant benefits
Partnered and applied research that will support the biomanufacturing and life sciences sector The results of the research activities provide significant social, economic and/or health impact(s) in support of pandemic readiness and response to emerging health threats by capitalizing on known strengths and/or addressing key research gaps to benefit Canada’s biomanufacturing and life sciences sector.
Commercialization, technology transfer and/or knowledge mobilization plans are in place The component describes a strategy for commercialization, technology transfer and/or knowledge mobilization, as appropriate. The strategy is feasible, considers the available resources, engagement of end-users and intellectual property protection, where appropriate.
Support for training and mentoring of HQP The research activities support the training and mentoring of HQP and will provide opportunities for their meaningful contribution.
Contribution of partners
Extent to which partners concretely contribute to the research component
Appropriateness of partners The component includes partners and collaborators from various disciplines and sectors (academic, public, private, industry and not-for-profit), as appropriate. The partners and collaborators are relevant to the research activities and will support innovation, mobilize results and accelerate the translation of promising discoveries into products and services relevant to the biomanufacturing and life sciences sector.
Contribution of partners Partners have been involved in the design of the research component and are committed to facilitating, supporting and furthering its objectives. Partner engagement and commitment are demonstrated through participation in the research activities, financial and/or in-kind contributions.
Equity, diversity and inclusion (EDI) and early career researchers (ECRs)
Extent to which commitment to EDI and ECRs is demonstrated in the research component
Actions to remove barriers and ensure opportunities for the recruitment and retention of individuals from underrepresented groups and ECRs The approach describes ongoing and rigorous actions to identify, address and mitigate systemic barriers that may result in individuals from underrepresented groups (including but not limited to racialized groups, Indigenous Peoples, persons with disabilities, women, and individuals from 2SLGBTQIA+ communities) having unequal access to or being excluded from participating in research activities. The approach describes and addresses challenges or systemic barriers that could prevent equitable participation within the research environment. The approach includes actions to meaningfully include underrepresented groups and ECRs. Principles of equity and diversity were considered in the team composition.

Talent development criteria

Relevance
Extent to which the talent development component’s objectives and design meet the hub’s vision, priorities and program of research
Objectives and design support the hub’s vision, priorities and program of research The objectives and design are aligned with the hub’s vision, priorities and program of research and there is a clear link between the talent development component and the research component(s) it supports.
Effectiveness
Extent to which the talent development component is expected to achieve its objectives
Appropriateness and feasibility of the activities The component includes training modules, best practices, guidelines and/or curriculum materials that are feasible and appropriate to the expected outcomes. Infrastructure and tools described are appropriate for carrying out the talent development activities. There is a description of potential limitations and plans to mitigate these limitations, as appropriate.
Necessary expertise to deliver on the component’s objectives The team has the breadth and depth of expertise, perspectives and capacity from all relevant sectors and disciplines, including expertise in training and mentoring, to meet the objectives of the talent development component.
Efficiency
Extent to which the talent development component is likely to deliver results in an efficient and timely manner
Appropriateness of the scope and timeline The timeline is appropriate to the duration of the funding and sufficient to conduct the described activities and meet the objectives outlined.
Appropriateness of the budget The budget is appropriate to undertake and complete the outlined talent development activities.
Effectiveness of the oversight structure(s) and plan(s)

The described oversight structure(s) and/or administrative plan(s) reflect the objectives, breadth and complexity of the talent development component. Plans should include:

  • appropriate methods and indicators for monitoring progress and assessing outcomes; and
  • a description of the specific roles and expertise of governance structure members.
Impact
Extent to which the talent development component is expected to generate significant benefits
Extent to which the component supports the biomanufacturing and life sciences sector

The talent development activities support pandemic readiness and response to emerging health threats by providing a value-added experience to trainees and HQP. The activities enable the development of skills relevant to the biomanufacturing and life sciences sector, including:

  • industry-relevant skills in research, engineering and biomanufacturing;
  • training in Good Laboratory Practice and Good Manufacturing Practice laboratories and facilities, where appropriate; and
  • training in approaches to advance rigorous and responsible research (e.g., SGBA and/or GBA+, data management, engagement with Indigenous Peoples, ethics, unconscious bias).
Extent to which the talent development component promotes mobility of HQP and facilitates the transition to careers within and beyond academia

The talent development activities include workshops and conferences, internships with a mentoring component and/or co-op and outreach programs that:

  • provide opportunities for HQP to transition to careers within and beyond academia;
  • promote and encourage national and, where applicable, international mobility across sectors and disciplines;
  • promote interaction of HQP with non-academic sectors (private companies, industry associations, not-for-profit organizations, government departments, etc.), as appropriate; and
  • promote links between HQP and prospective employers.
Contribution of partners
Extent to which partners concretely contribute to the talent development component
Appropriateness of partners The component includes partners and collaborators from various disciplines and sectors (academic, public, private, industry and not-for-profit), as appropriate. The partners and collaborators are appropriate to the talent development activities and will provide enriched training experiences, leading to the development of skills relevant to the biomanufacturing and life sciences sector as well as the supported research component(s).
Contribution of partners Partners have been involved in the design of the talent development component and are committed to facilitating, supporting and furthering its objectives. Partner engagement and commitment are demonstrated through participation in the talent development activities, financial and/or in-kind contributions.
Equity, diversity and inclusion (EDI) and early career researchers (ECRs)
Extent to which commitment to EDI and ECRs is demonstrated in the talent development component
Actions to remove systemic barriers and ensure opportunities for the recruitment and retention of individuals from underrepresented groups and ECRs The EDI approach describes ongoing and rigorous actions taken to identify, address and mitigate systemic barriers that may result in individuals from underrepresented groups (including but not limited to racialized groups, Indigenous Peoples, persons with disabilities, women, and individuals from 2SLGBTQIA+ communities) having unequal access to or being excluded from participating in talent development activities. The approach describes and addresses challenges or systemic barriers that could prevent equitable recruitment, selection, and participation of diverse trainees within the training environment. The approach includes actions to meaningfully include underrepresented groups and ECRs. Principles of equity and diversity were considered in the team composition.

Infrastructure criteria

Need
Extent to which the infrastructure component efficiently supports research component(s) submitted by institutions
The extent to which the infrastructure will support the ongoing research activities in the supported component(s) The requested infrastructure is appropriate to efficiently support the proposed research activities and/or future related research activities.
Appropriateness of the budget The budget is appropriate to acquire the infrastructure.
Building capacity
Extent to which the infrastructure component enhances the research capacity of the institution(s) to support the hub's, vision, priorities and program of research
Complementarity to existing capacity The requested infrastructure will complement and leverage existing infrastructure to enhance the capacity of the institution(s) to support the endorsing hub’s vision, priorities and program of research over the medium and long term.
Necessary expertise to make optimal use of the infrastructure The team involved in the infrastructure component collectively brings the necessary capacity and expertise to ensure the optimal use of the infrastructure.
Sustainability
Extent to which the infrastructure component will be optimally used and maintained over its useful life
Effectiveness of the oversight plan(s)

The oversight structure(s) and plan(s) in place are tailored to the breadth and complexity of the infrastructure component and are appropriate to effectively oversee the ongoing operation and maintenance of the requested infrastructure. Plans should include:

  • a description of the expertise and roles of the team members involved in oversight activities; and
  • data management considerations, as appropriate.
Appropriateness of the financial resources for operation and maintenance

The operating and maintenance costs outlined in the infrastructure component are appropriate and sufficient to sustain the infrastructure over its useful life. Funds for operating and maintaining the infrastructure are secured or a plan to secure funds is provided and includes:

  • an appropriate allocation of resources;
  • a contingency plan for potential funding shortfalls; and
  • diversified revenue and funding sources, as appropriate.
Equitable access to the infrastructure The EDI approach describes ongoing and rigorous actions to support ECRs and mitigate systemic barriers that may result in individuals from underrepresented groups having unequal access to or being excluded from accessing the infrastructure. The approach describes and addresses the specific challenges or systemic barriers that could prevent equitable access.

Strategic selection criteria

Evaluation of the strategic selection criteria by the Strategic Review Committee is supported by the hub endorsement report (Word document, 63 Kb) and the strategic overview (Word document, 63 Kb).

Relevance
Extent to which the proposal’s objectives and design respond to the strategic objectives and the Strategy
The proposal supports one or more strategic objectives and is aligned with the Strategy The proposal’s objectives are aligned with Canada’s Biomanufacturing and Life Sciences Strategy and one or more of the strategic objectives of the funding opportunity.
Impact
Extent to which the proposal is expected to generate significant benefits for Canada
The proposal has the potential to significantly contribute to advancing Canada’s key bio-innovation capabilities The proposal bolsters Canada’s key bio-innovation capabilities and the Canadian biomanufacturing and life sciences sector by improving Canada’s pandemic readiness and domestic capacity to produce life-saving vaccines and therapeutics. The impacts and benefits to Canada go beyond academic outcomes and include building capacity to accelerate the translation of promising discoveries into products and services by leveraging cross-sector and multidisciplinary partnerships.
Coherence
Extent to which the proposal complements other proposals within and across hubs
Complementarity of the proposal to other proposals within and across hubs In combination with the proposals submitted within and across hubs, the proposal contributes to a coherent, coordinated and effective program of research. The proposal leverages and complements proposals submitted within and across hubs to bolster areas in which Canadian research is cutting-edge, while addressing critical gaps in the biomanufacturing and life sciences sector.

Date modified: